Description

Exobiosphere is a biotech company whose work is anchored in a proprietary miniaturized , robust, and autonomous platform that uses living human in vitro models to study biological responses in extreme environments — delivering defence solutions across space, air, and ground. On the ground, the systems biological intelligence forms the basis of an autonomous CBRN detection system designed to identify chemical, biological, radiological, and nuclear threats — including unknown and engineered agents that evade conventional signature-based sensors — delivering human-relevant threat intelligence directly to command. In the air, a fighter jet-adapted version opens a novel research pathway for studying G-force-induced neurodegeneration in elite pilots — an accelerating and underserved threat to aircrew readiness. In space, the platform accelerates research directly relevant to warfighter health and human performance, including soldier injury recovery, immune resilience, and countermeasure development. Headquartered in Luxembourg, Exobiosphere collaborates with research institutions, biotechs, space agencies, and military partners to advance bio-driven innovations in defence.

Themes

SpaceLand

Email

defence@exobiosphere.com

Media

Exobiosphere - Defence Applications